By Aimee Look


Reckitt Benckiser booked higher revenue last year, with the Lysol disinfectant maker's sales boosted by progress in emerging markets as it continues efforts to engineer a turnaround.

The British consumer-goods giant, which also makes products like Durex condoms and Mucinex cold medicine, said Thursday that net sales rose to 14.21 billion pounds ($19 billion) in 2025 from 14.17 billion pounds the year before, helped by growth in emerging markets. The result slightly missed market expectations of 14.23 billion pounds, according to estimates compiled by the company.

On a like-for-like basis, sales grew 5% on year, Reckitt said.

Pretax profit jumped to 3.84 billion pounds from 2.10 billion pounds.

For the year ahead, Reckitt expects core like-for-like revenue to rise by 4% to 5%, which is in line with medium-term guidance.


Write to Aimee Look at aimee.look@wsj.com


(END) Dow Jones Newswires

03-05-26 0254ET